4//SEC Filing
Giordano Michael F 4
Accession 0001209191-20-039146
CIK 0001673772other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:49 PM ET
Size
12.8 KB
Accession
0001209191-20-039146
Insider Transaction Report
Form 4
Giordano Michael F
Director
Transactions
- Exercise/Conversion
Common Stock
2020-06-25$6.18/sh+10,069$62,226→ 10,069 total - Exercise/Conversion
Common Stock
2020-06-25$12.00/sh+8,944$107,328→ 8,944 total - Exercise/Conversion
Stock Option (right to buy)
2020-06-25−10,069→ 6,597 totalExercise: $6.18Exp: 2028-03-27→ Common Stock (10,069 underlying) - Exercise/Conversion
Stock Option (right to buy)
2020-06-25−8,944→ 6,390 totalExercise: $12.00Exp: 2029-10-29→ Common Stock (8,944 underlying) - Sale
Common Stock
2020-06-25$33.37/sh−19,013$634,464→ 0 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $34.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date.
- [F3]The shares subject to the option vest in 12 equal monthly installments from the vesting commencement date.
Documents
Issuer
RAPT Therapeutics, Inc.
CIK 0001673772
Entity typeother
Related Parties
1- filerCIK 0001733915
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 5:49 PM ET
- Size
- 12.8 KB